The Pennant Group (NASDAQ:PNTG) Cut to “D+” at TheStreet
TheStreet cut shares of The Pennant Group (NASDAQ:PNTG) from a c- rating to a d+ rating in a research report report published on Monday morning, TheStreetRatingsTable reports.
PNTG has been the subject of several other reports. Truist Financial increased their price objective on The Pennant Group from $44.00 to $60.00 in a research report on Tuesday, January 5th. Zacks Investment Research raised The Pennant Group from a hold rating to a buy rating and set a $70.00 price objective for the company in a research report on Tuesday, January 26th. Two investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. The Pennant Group currently has an average rating of Buy and an average target price of $49.20.
Shares of NASDAQ PNTG opened at $43.53 on Monday. The company has a current ratio of 0.64, a quick ratio of 0.64 and a debt-to-equity ratio of 0.01. The company has a 50-day moving average of $50.95 and a 200 day moving average of $50.79. The Pennant Group has a 12-month low of $15.48 and a 12-month high of $69.56. The stock has a market cap of $1.23 billion, a PE ratio of 167.43 and a beta of 2.83.
In other The Pennant Group news, CEO Daniel H. Walker sold 40,000 shares of the firm’s stock in a transaction that occurred on Friday, January 15th. The shares were sold at an average price of $59.07, for a total value of $2,362,800.00. Following the completion of the transaction, the chief executive officer now owns 1,193,691 shares of the company’s stock, valued at approximately $70,511,327.37. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Daniel H. Walker sold 22,353 shares of the business’s stock in a transaction on Tuesday, February 2nd. The stock was sold at an average price of $54.29, for a total transaction of $1,213,544.37. Following the completion of the transaction, the chief executive officer now owns 1,193,691 shares of the company’s stock, valued at approximately $64,805,484.39. The disclosure for this sale can be found here. Insiders sold 62,448 shares of company stock valued at $3,581,890 over the last ninety days. Insiders own 10.40% of the company’s stock.
A number of large investors have recently added to or reduced their stakes in PNTG. BlackRock Inc. grew its stake in The Pennant Group by 4.2% during the 4th quarter. BlackRock Inc. now owns 3,871,283 shares of the company’s stock worth $224,767,000 after purchasing an additional 155,969 shares in the last quarter. Riverbridge Partners LLC boosted its stake in shares of The Pennant Group by 12.7% in the 4th quarter. Riverbridge Partners LLC now owns 653,586 shares of the company’s stock valued at $37,947,000 after buying an additional 73,430 shares during the period. Nuveen Asset Management LLC grew its position in shares of The Pennant Group by 4.0% during the fourth quarter. Nuveen Asset Management LLC now owns 301,501 shares of the company’s stock worth $17,505,000 after buying an additional 11,725 shares in the last quarter. Norges Bank acquired a new position in shares of The Pennant Group during the fourth quarter worth about $16,546,000. Finally, Charles Schwab Investment Management Inc. increased its stake in shares of The Pennant Group by 2.2% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 167,760 shares of the company’s stock worth $9,741,000 after buying an additional 3,569 shares during the period. Hedge funds and other institutional investors own 79.31% of the company’s stock.
About The Pennant Group
The Pennant Group, Inc provides healthcare services in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.
Recommended Story: Why do company’s buyback their stock?
Receive News & Ratings for The Pennant Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Pennant Group and related companies with MarketBeat.com's FREE daily email newsletter.